2m 2m 2m 2m 2m 2m 2m
SUTRO BIOPHARMA (STRO)
NASDAQ
$20.98-$0.06 (-0.29%)
Price as of Aug 21, 2026 7:32 PM EDT- $348.9MMarket Cap
- 145.28%1-Year Change
- BiotechnologyIndustry
SUTRO BIOPHARMA (STRO)
$20.98-$0.06 (-0.29%)
STRO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $21.04 | ||
Change | -$0.12 (-0.57%) | ||
Open | $21.39 | ||
High | $21.86 | ||
Low | $20.84 | ||
Previous Close | $21.16 | ||
Volume | 194,683 | ||
30-Day Average Volume | 294,351 | ||
1-Week Change | 2.73% | ||
1-Month Change | -8.52% | ||
1-Year Change | 145.28% | ||
3-Year Change | -54.56% | ||
5-Year Change | -89.01% | ||
Fundamentals | |||
Shares Outstanding | 16.6M | ||
Total Assets | $194.5M | ||
Market Cap | $348.9M | ||
Enterprise Value | $294.5M | ||
Period: QTR TTM FY | |||
Revenue | $9.8M | ||
Net Income | -$38.5M | ||
Free Cash Flow | -$38.3M | ||
EBIT | -$38.5M | ||
EBITDA | -$37.3M | ||
Net Working Capital | $122.7M | ||
EPS | -$2.33 | ||
Enterprise Value/EBITDA | -8 | ||
Enterprise Value/Revenue | 30 | ||
P/B | -3 | ||
P/E | -9 | ||
PEG | -0 | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 12/03/2025 | ||
Earnings & Revenue